The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Genomics Biomarkers-Global Market Insights and Sales Trends 2024
Synopsis
A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of one or more deoxyribonucleic acid (DNA) and/or ribonucleic acid (RNA).
The global Genomics Biomarkers market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Genomics Biomarkers in various end use industries. The expanding demands from the Diagnostic and Research Laboratories and Hospitals, are propelling Genomics Biomarkers market. Oncology, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cardiovascular Diseases segment is estimated at % CAGR for the next seven-year period.
The increasing instances of low-cost clinical trials in developing countries will drive the growth prospects for the global genomics biomarkers market until the end of 2021. This globalization of clinical trials has been credited to numerous components that include organized trials, the willingness of members facilitating the enrollment, accessibility of qualified local investigators, enhanced opportunities in various Tier 2 and Tier 3 countries, and lower expenses of clinical trials in developing nations. Some of the other factors responsible for the increasing preference for disease-based genomic biomarkers such as cancer biomarkers testing includes the faster and precise analysis of diseases and potential lowering in volume and time involved in clinical trials.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genomics Biomarkers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genomics Biomarkers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genomics Biomarkers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genomics Biomarkers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genomics Biomarkers covered in this report include Roche Diagnostics, Myriad Genetics, QIAGEN, Thermo Fisher Scientific and Bio-Rad Laboratories, etc.
The global Genomics Biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche Diagnostics
Myriad Genetics
QIAGEN
Thermo Fisher Scientific
Bio-Rad Laboratories
Global Genomics Biomarkers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genomics Biomarkers market, Segment by Type:
Oncology
Cardiovascular Diseases
Neurological Diseases
Global Genomics Biomarkers market, by Application
Diagnostic and Research Laboratories
Hospitals
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genomics Biomarkers companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of one or more deoxyribonucleic acid (DNA) and/or ribonucleic acid (RNA).
The global Genomics Biomarkers market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Genomics Biomarkers in various end use industries. The expanding demands from the Diagnostic and Research Laboratories and Hospitals, are propelling Genomics Biomarkers market. Oncology, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cardiovascular Diseases segment is estimated at % CAGR for the next seven-year period.
The increasing instances of low-cost clinical trials in developing countries will drive the growth prospects for the global genomics biomarkers market until the end of 2021. This globalization of clinical trials has been credited to numerous components that include organized trials, the willingness of members facilitating the enrollment, accessibility of qualified local investigators, enhanced opportunities in various Tier 2 and Tier 3 countries, and lower expenses of clinical trials in developing nations. Some of the other factors responsible for the increasing preference for disease-based genomic biomarkers such as cancer biomarkers testing includes the faster and precise analysis of diseases and potential lowering in volume and time involved in clinical trials.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genomics Biomarkers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genomics Biomarkers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genomics Biomarkers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genomics Biomarkers sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genomics Biomarkers covered in this report include Roche Diagnostics, Myriad Genetics, QIAGEN, Thermo Fisher Scientific and Bio-Rad Laboratories, etc.
The global Genomics Biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche Diagnostics
Myriad Genetics
QIAGEN
Thermo Fisher Scientific
Bio-Rad Laboratories
Global Genomics Biomarkers market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genomics Biomarkers market, Segment by Type:
Oncology
Cardiovascular Diseases
Neurological Diseases
Global Genomics Biomarkers market, by Application
Diagnostic and Research Laboratories
Hospitals
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genomics Biomarkers companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Genomics Biomarkers
1.1 Genomics Biomarkers Market Overview
1.1.1 Genomics Biomarkers Product Scope
1.1.2 Genomics Biomarkers Market Status and Outlook
1.2 Global Genomics Biomarkers Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Genomics Biomarkers Market Size by Region (2018-2029)
1.4 Global Genomics Biomarkers Historic Market Size by Region (2018-2023)
1.5 Global Genomics Biomarkers Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Genomics Biomarkers Market Size (2018-2029)
1.6.1 North America Genomics Biomarkers Market Size (2018-2029)
1.6.2 Europe Genomics Biomarkers Market Size (2018-2029)
1.6.3 Asia-Pacific Genomics Biomarkers Market Size (2018-2029)
1.6.4 Latin America Genomics Biomarkers Market Size (2018-2029)
1.6.5 Middle East & Africa Genomics Biomarkers Market Size (2018-2029)
2 Genomics Biomarkers Market by Type
2.1 Introduction
2.1.1 Oncology
2.1.2 Cardiovascular Diseases
2.1.3 Neurological Diseases
2.2 Global Genomics Biomarkers Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Genomics Biomarkers Historic Market Size by Type (2018-2023)
2.2.2 Global Genomics Biomarkers Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Genomics Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Genomics Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Genomics Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Genomics Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Genomics Biomarkers Revenue Breakdown by Type (2018-2029)
3 Genomics Biomarkers Market Overview by Application
3.1 Introduction
3.1.1 Diagnostic and Research Laboratories
3.1.2 Hospitals
3.2 Global Genomics Biomarkers Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Genomics Biomarkers Historic Market Size by Application (2018-2023)
3.2.2 Global Genomics Biomarkers Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Genomics Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Genomics Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Genomics Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Genomics Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Genomics Biomarkers Revenue Breakdown by Application (2018-2029)
4 Genomics Biomarkers Competition Analysis by Players
4.1 Global Genomics Biomarkers Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genomics Biomarkers as of 2022)
4.3 Date of Key Players Enter into Genomics Biomarkers Market
4.4 Global Top Players Genomics Biomarkers Headquarters and Area Served
4.5 Key Players Genomics Biomarkers Product Solution and Service
4.6 Competitive Status
4.6.1 Genomics Biomarkers Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche Diagnostics
5.1.1 Roche Diagnostics Profile
5.1.2 Roche Diagnostics Main Business
5.1.3 Roche Diagnostics Genomics Biomarkers Products, Services and Solutions
5.1.4 Roche Diagnostics Genomics Biomarkers Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Diagnostics Recent Developments
5.2 Myriad Genetics
5.2.1 Myriad Genetics Profile
5.2.2 Myriad Genetics Main Business
5.2.3 Myriad Genetics Genomics Biomarkers Products, Services and Solutions
5.2.4 Myriad Genetics Genomics Biomarkers Revenue (US$ Million) & (2018-2023)
5.2.5 Myriad Genetics Recent Developments
5.3 QIAGEN
5.3.1 QIAGEN Profile
5.3.2 QIAGEN Main Business
5.3.3 QIAGEN Genomics Biomarkers Products, Services and Solutions
5.3.4 QIAGEN Genomics Biomarkers Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fisher Scientific Recent Developments
5.4 Thermo Fisher Scientific
5.4.1 Thermo Fisher Scientific Profile
5.4.2 Thermo Fisher Scientific Main Business
5.4.3 Thermo Fisher Scientific Genomics Biomarkers Products, Services and Solutions
5.4.4 Thermo Fisher Scientific Genomics Biomarkers Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fisher Scientific Recent Developments
5.5 Bio-Rad Laboratories
5.5.1 Bio-Rad Laboratories Profile
5.5.2 Bio-Rad Laboratories Main Business
5.5.3 Bio-Rad Laboratories Genomics Biomarkers Products, Services and Solutions
5.5.4 Bio-Rad Laboratories Genomics Biomarkers Revenue (US$ Million) & (2018-2023)
5.5.5 Bio-Rad Laboratories Recent Developments
6 North America
6.1 North America Genomics Biomarkers Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Genomics Biomarkers Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Genomics Biomarkers Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Genomics Biomarkers Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Genomics Biomarkers Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Genomics Biomarkers Market Dynamics
11.1 Genomics Biomarkers Industry Trends
11.2 Genomics Biomarkers Market Drivers
11.3 Genomics Biomarkers Market Challenges
11.4 Genomics Biomarkers Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
